Compare NBN & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBN | INMD |
|---|---|---|
| Founded | 1872 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 836.7M | 879.2M |
| IPO Year | N/A | 2019 |
| Metric | NBN | INMD |
|---|---|---|
| Price | $116.07 | $13.93 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $102.00 | $16.75 |
| AVG Volume (30 Days) | 126.4K | ★ 682.3K |
| Earning Date | 02-05-2026 | 02-10-2026 |
| Dividend Yield | ★ 0.04% | N/A |
| EPS Growth | ★ 38.19 | 20.42 |
| EPS | ★ 10.63 | 2.21 |
| Revenue | $214,699,000.00 | ★ $364,494,000.00 |
| Revenue This Year | $11.59 | N/A |
| Revenue Next Year | $11.26 | $3.33 |
| P/E Ratio | $10.74 | ★ $6.30 |
| Revenue Growth | ★ 36.17 | N/A |
| 52 Week Low | $78.17 | $13.14 |
| 52 Week High | $117.28 | $19.78 |
| Indicator | NBN | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 67.93 | 39.45 |
| Support Level | $105.21 | $13.89 |
| Resistance Level | $113.47 | $14.59 |
| Average True Range (ATR) | 3.69 | 0.42 |
| MACD | 0.28 | -0.12 |
| Stochastic Oscillator | 79.86 | 1.37 |
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.